Efficacy and safety of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m2
- Danne, T.
- Edelman, S.
- Frias, J.P.
- Ampudia-Blasco, F.J.
- Banks, P.
- Jiang, W.
- Davies, M.J.
- Sawhney, S.
ISSN: 1463-1326, 1462-8902
Ano de publicación: 2021
Volume: 23
Número: 3
Páxinas: 854-860
Tipo: Artigo